Cargando…
Improvement of fluvastatin bioavailability by loading on nanostructured lipid carriers
The aim of this study is to prepare fluvastatin nanostructured lipid carriers (FLV-NLCs) in order to find an innovative way to alleviate FLV-associated disadvantages. The limitations include poor solubility and extensive first-pass metabolism, resulting in low (30%) bioavailability and short elimina...
Autores principales: | El-Helw, Abdel-Rahim M, Fahmy, Usama A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4577263/ https://www.ncbi.nlm.nih.gov/pubmed/26396513 http://dx.doi.org/10.2147/IJN.S91556 |
Ejemplares similares
-
Improvement of oral bioavailability of lovastatin by using nanostructured lipid carriers
por: Zhou, Jun, et al.
Publicado: (2015) -
Oral Bioavailability Enhancement of Raloxifene with Nanostructured Lipid Carriers
por: Murthy, Aditya, et al.
Publicado: (2020) -
Oral bioavailability enhancement of agomelatine by loading into nanostructured lipid carriers: Peyer’s patch targeting approach
por: Prajapati, Jagruti B, et al.
Publicado: (2018) -
Enhanced oral bioavailability of fluvastatin by using nanosuspensions containing cyclodextrin
por: Li, Jun, et al.
Publicado: (2018) -
Nanostructured lipid carriers: An emerging platform for improving oral bioavailability of lipophilic drugs
por: Khan, Saba, et al.
Publicado: (2015)